1. Adelaide Research & Scholarship
  2. Schools and Disciplines
  3. School of Medicine
  4. Medicine
  5. Medicine publications
Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/57218
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHiwase, D.-
dc.contributor.authorWhite, D.-
dc.contributor.authorZrim, S.-
dc.contributor.authorSaunders, V.-
dc.contributor.authorVaz de Melo, J.-
dc.contributor.authorHughes, T.-
dc.date.issued2010-
dc.identifier.citationLeukemia, 2010; 24(3):658-660-
dc.identifier.issn0887-6924-
dc.identifier.issn1476-5551-
dc.identifier.urihttp://hdl.handle.net/2440/57218-
dc.description.statementofresponsibilityDK Hiwase, D White, S Zrim, V Saunders, J V Melo and T P Hughes-
dc.language.isoen-
dc.publisherNature Publishing Group-
dc.source.urihttp://dx.doi.org/10.1038/leu.2009.242-
dc.subjectK562 Cells-
dc.subjectHumans-
dc.subjectPyrimidines-
dc.subjectThiazoles-
dc.subjectAntineoplastic Combined Chemotherapy Protocols-
dc.subjectProtein Kinase Inhibitors-
dc.subjectDrug Synergism-
dc.subjectLeukemia, Myelogenous, Chronic, BCR-ABL Positive-
dc.subjectDasatinib-
dc.subjectATP Binding Cassette Transporter, Subfamily B-
dc.subjectATP Binding Cassette Transporter, Subfamily B, Member 1-
dc.titleNilotinib-mediated inhibition of ABCB1 increases intracellular concentration of dasatinib in CML cells: implications for combination TKI therapy-
dc.typeJournal article-
dc.identifier.doi10.1038/leu.2009.242-
pubs.publication-statusPublished-
dc.identifier.orcidHiwase, D. [0000-0002-6666-3056]-
dc.identifier.orcidWhite, D. [0000-0003-4844-333X]-
dc.identifier.orcidHughes, T. [0000-0002-0910-3730] [0000-0002-7990-4509]-
Appears in Collections:Aurora harvest 5
Medicine publications

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.